Clostridium novyi, sordellii, and tetani: Mechanisms of disease

Anaerobe

Volumn 24, Issue , 2013, Pages 98-101

  Aronoff, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Large clostridial cytotoxins; Tetanus; Toxic shock syndrome

Indexed keywords

CLOSTRIDIUM TOXIN; CYTOTOXIN; HEMORRHAGIC TOXIN; TETANOSPASMIN; TETANUS TOXIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL SPORE; BACTERIAL VIRULENCE; CLINICAL FEATURE; CLOSTRIDIUM INFECTION; CLOSTRIDIUM NOVYI; CLOSTRIDIUM SORDELLII; CLOSTRIDIUM TETANI; GAS GANGRENE; HOST CELL; HUMAN; INTOXICATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPORE GERMINATION; TETANUS; TOXIC SHOCK SYNDROME; TRISMUS;

CLOSTRIDIA; CLOSTRIDIUM NOVYI; CLOSTRIDIUM SORDELLII; CLOSTRIDIUM TETANI; POSIBACTERIA;

LARGE CLOSTRIDIAL CYTOTOXINS; TETANUS; TOXIC SHOCK SYNDROME;

CLOSTRIDIUM; CLOSTRIDIUM INFECTIONS; HUMANS; SHOCK, SEPTIC; TETANUS;

EID: 84889080262     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.08.009     Document Type: Article

References (31)

1. Popoff M.R., Bouvet P. Clostridial toxins. Future Microbiol 2009, 4:1021-1064.
2. Kaushik K.S., Kapila K., Praharaj A.K. Shooting up: the interface of microbial infections and drug abuse. JMed Microbiol 2011, 60:408-422.
3. Afshar M., Raju M., Ansell D., Bleck T.P. Narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Intern Med 2011, 154:329-335.
4. Ataro P., Mushatt D., Ahsan S. Tetanus: a review. South Med J 2011, 104:613-617.
5. Caleo M., Schiavo G. Central effects of tetanus and botulinum neurotoxins. Toxicon 2009, 54:593-599.
6. Farrar J.J., Yen L.M., Cook T., Fairweather N., Binh N., Parry J., et al. Tetanus. JNeurol Neurosurg Psychiatr 2000, 69:292-301.
7. Blum F.C., Chen C., Kroken A.R., Barbieri J.T. Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Infect Immun 2012, 80:1662-1669.
8. Novy F. Ein neuer anaërober Bacillus des malignen Oedems. Medical Microbiol Immunol 1894, 17:209-232.
9. Maclennan J.D. The histotoxic clostridial infections of man. Bacteriol Rev 1962, 26:177-276.
10. Ryan J.M., Paul J., Curtis S., Patel N.K. Clostridium novyi infection: a fatal association with injecting drug users. Emerg Med J 2001, 18:138-139.
11. McGuigan C.C., Penrice G.M., Gruer L., Ahmed S., Goldberg D., Black M., et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. JMed Microbiol 2002, 51:971-977.
12. Finn S.P., Leen E., English L., O'Briain D.S. Autopsy findings in an outbreak of severe systemic illness in heroin users following injection site inflammation: an effect of Clostridium novyi exotoxin?. Arch Pathol Lab Med 2003, 127:1465-1470.
13. Aldape M.J., Bryant A.E., Stevens D.L. Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. Clin Infect Dis 2006, 43:1436-1446.
14. Zane S., Guarner J. Gynecologic clostridial toxic shock in women of reproductive age. Curr Infect Dis Rep 2011, 13:561-570.
15. Izumi N., Niiro M., Kondo H. Clostridium oedematiens type A toxin: the correlation between the lethal and edematizing activities. Jpn J Med Sci Biol 1983, 36:67-74.
16. Bette P., Oksche A., Mauler F., von Eichel-Streiber C., Popoff M.R., Habermann E. Acomparative biochemical, pharmacological and immunological study of Clostridium novyi alpha-toxin, C.difficile toxin B and C.sordellii lethal toxin. Toxicon 1991, 29:877-887.
17. Dang L.H., Bettegowda C., Huso D.L., Kinzler K.W., Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 2001, 98:15155-15160.
18. Fischer M., Bhatnagar J., Guarner J., Reagan S., Hacker J.K., Van Meter S.H., et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. NEngl J Med 2005, 353:2352-2360.
19. Bangsberg D.R., Rosen J.I., Aragon T., Campbell A., Weir L., Perdreau-Remington F. Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation. Arch Intern Med 2002, 162:517-522.
20. Kainer M.A., Linden J.V., Whaley D.N., Holmes H.T., Jarvis W.R., Jernigan D.B., et al. Clostridium infections associated with musculoskeletal-tissue allografts. NEngl J Med 2004, 350:2564-2571.
21. Aronoff D.M., Ballard J.D. Clostridium sordellii toxic shock syndrome. Lancet Infect Dis 2009, 9:725-726.
22. Lappin E., Ferguson A.J. Gram-positive toxic shock syndromes. Lancet Infect Dis 2009, 9:281-290.
23. Geny B., Khun H., Fitting C., Zarantonelli L., Mazuet C., Cayet N., et al. Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability. Am J Pathol 2007, 170:1003-1017.
24. Chang T.W., Gorbach S.L., Bartlett J.B. Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins. Infect Immun 1978, 22:418-422.
25. Martinez R.D., Wilkins T.D. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). Infect Immun 1988, 56:1215-1221.
26. Martinez R.D., Wilkins T.D. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C.difficile. JMed Microbiol 1992, 36:30-36.
27. Popoff M.R. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. Infect Immun 1987, 55:35-43.
28. Zeiser J., Gerhard R., Just I., Pich A. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques. JProteome Res 2013.
29. Walk S.T., Jain R., Trivedi I., Grossman S., Newton D.W., Thelen T., et al. Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia. Anaerobe 2011, 17:252-256.
30. Hao Y., Senn T., Opp J.S., Young V.B., Thiele T., Srinivas G., et al. Lethal toxin is a critical determinant of rapid mortality in rodent models of Clostridium sordellii endometritis. Anaerobe 2010, 16:155-160.
31. Kowluru A., Li G., Rabaglia M.E., Segu V.B., Hofmann F., Aktories K., et al. Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose- and calcium-induced insulin secretion from pancreatic beta cells. Biochem Pharmacol 1997, 54:1097-1108.